Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04201288 · ClinicalTrials.gov registry record · NA
Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients
A NA study, sponsored by Brown University.
- Completed
- Registry status
- NA
- Development phase
- 38
- Enrollment target
NCT04201288: Completed NA study, sponsored by Brown University.
NCT04201288 is a NA study that has completed, run by Brown University. The registered enrollment target is 38 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04201288, a NA study, has completed, sponsored by Brown University.
- COMPLETED
- Registry status
- NA
- Development phase
- 38 participants
- Enrollment target
Study Summary
The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care. The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To achieve the specific aims, the investigators will conduct a randomized clinical trial (n = 270), with two treatment arms: ABBT vs. an attention-matched HIV education control condition.
Primary Outcome
Objective data from participants' electronic health records will be obtained to examine how many medical appointments they attended in the past year at their HIV treatment clinic. Participants will be deemed as sufficiently retained if they attend at least 3 medical visits during this period.
Interventions
- BEHAVIORAL Acceptance-Based Behavior Therapy (ABBT)
- BEHAVIORAL Enhanced-Treatment-as-Usual (ETAU)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2020-12-21 |
| Est. Completion | 2025-03-31 |
| Phase | NA |
What the finished NCT04201288 record still lists
NCT04201288 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 38 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 2 interventions - of which Acceptance-Based Behavior Therapy (ABBT) is the first listed.
NCT04201288 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04201288 about?
NCT04201288 is a clinical study titled "Brief Acceptance-Based Retention Intervention for Newly Diagnosed HIV Patients". The overall aim of this program of research is to test a newly developed intervention, Acceptance-Based Behavior Therapy (ABBT), to improve HIV patients' commitment to medical care. The purpose of the proposed project is to establish the efficacy of ABBT and examine its mechanisms of action. To ach...
What is the current status of trial NCT04201288?
This trial is currently completed. It is a NA study. The enrollment target is 38 participants. The study started on 2020-12-21. Estimated completion is 2025-03-31.
What interventions are being tested in trial NCT04201288?
The interventions under investigation include: Acceptance-Based Behavior Therapy (ABBT) (BEHAVIORAL), Enhanced-Treatment-as-Usual (ETAU) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04201288?
This trial is sponsored by Brown University, which has 231 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04201288's enrollment target sits among peer trials
38 1538th of 2000 higher than 461 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01684904 · 38 participants · NA
Proton Therapy for Esophageal Cancer
- NCT03310879 · 38 participants · Phase 2
Study of the CDK4/6 Inhibitor Abemaciclib in Solid Tumors Harboring Genetic Alterations in Genes Encoding D-Type Cyclins or Amplification of CDK4 or CDK6
- NCT03896269 · 38 participants · Phase 1
CPX-351 in Treating Patients With Relapsed or Refractory High Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia
- NCT04085315 · 38 participants · Phase 1
Alisertib in Combination With Osimertinib in Metastatic EGFR-mutant Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI